Medical Cannabis News & Information

Cannabis Science Initiates Preclinical Investigation of CS-TATI-1 for European Studies for Squamous/Basal Cell Carcinomas and Kaposi's Sarcoma

on . Posted in Medical Cannabis News & Information

Concept Sheet Development for Cell Line Activity and Animal Model Pharmacokinetics for European Agency Review to be Initiated in 4Q

COLORADO SPRINGS, Colo., Sep 24, 2012 (BUSINESS WIRE) -- Cannabis Science (nasd otc:CBIS), a pioneering U.S. Biotech Company developing pharmaceutical products for global public health challenges, is pleased to announce preclinical investigations being initiated in Europe for Squamous/Basal Cell carcinomas and Kaposi's sarcoma based on inhibition of carcinogenicity utilizing cannabinoids that have been demonstrated in recent studies to significantly affect tumor necrosis.